Evidence map›Paper›PMID 31383872›Full record

ArticleScientific reports2019

Integrated genomic epidemiology and phenotypic profiling of Clostridium difficile across intra-hospital and community populations in Colombia.

Marina Muñoz, Daniel Restrepo-Montoya, Nitin Kumar, Gregorio Iraola, Milena Camargo, Diana Díaz-Arévalo, Nelly S Roa-Molina, Mayra A Tellez, Giovanny Herrera, Dora I Ríos-Chaparro and 8 more

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Phenotypic analysis of variousApplied and environmental microbiology · 2025
    Article
  3. Article
  4. Genomic study of EuropeanMicrobial genomics · 2024
    Article
  5. Review
  6. International journal of molecular sciences · 2023
    Review
  7. Cytotoxic synergism ofWorld journal of gastroenterology · 2023
    Review
  8. Detection and Genomic Characterisation ofPathogens (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Invisible steps for a global endemy: molecular strategies adopted byTherapeutic advances in gastroenterology · 2021
    Review
  13. Occurrence ofPathogens (Basel, Switzerland) · 2020
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Marina MuñozGrupo de Investigaciones Microbiológicas-UR (GIMUR), Departamento de Biología, Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Bogotá, Colombia.
Daniel Restrepo-MontoyaGrupo de Investigaciones Microbiológicas-UR (GIMUR), Departamento de Biología, Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Bogotá, Colombia.
Nitin KumarHost-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-2140-4923
Gregorio IraolaMicrobial Genomics Laboratory, Institut Pasteur Montevideo, Montevideo, Uruguay.ORCID http://orcid.org/0000-0002-6516-3404
Milena CamargoMolecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia.
Diana Díaz-ArévaloMolecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia.ORCID http://orcid.org/0000-0003-3766-5500
Nelly S Roa-MolinaCentro de Investigaciones Odontológicas, Facultad de Odontología, Pontificia Universidad Javeriana, Bogotá, Colombia.
Mayra A TellezCentro de Investigaciones Odontológicas, Facultad de Odontología, Pontificia Universidad Javeriana, Bogotá, Colombia.
Giovanny HerreraGrupo de Investigaciones Microbiológicas-UR (GIMUR), Departamento de Biología, Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Bogotá, Colombia.
Dora I Ríos-ChaparroGrupo de Investigaciones Microbiológicas-UR (GIMUR), Departamento de Biología, Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Bogotá, Colombia.
Claudia BirchenallHospital Universitario Mayor - Méderi, Universidad del Rosario, Bogotá, Colombia.
Darío PinillaHospital Universitario Mayor - Méderi, Universidad del Rosario, Bogotá, Colombia.
Juan M Pardo-OviedoHospital Universitario Mayor - Méderi, Universidad del Rosario, Bogotá, Colombia.ORCID http://orcid.org/0000-0003-0084-3449
Giovanni Rodríguez-LeguizamónHospital Universitario Mayor - Méderi, Universidad del Rosario, Bogotá, Colombia.
Diego F JosaFundación Clínica Shaio, Bogotá, Colombia.
Trevor D LawleyHost-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK.
Manuel A PatarroyoMolecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá, Colombia.ORCID http://orcid.org/0000-0002-4751-2500
Juan David RamírezGrupo de Investigaciones Microbiológicas-UR (GIMUR), Departamento de Biología, Facultad de Ciencias Naturales y Matemáticas, Universidad del Rosario, Bogotá, Colombia. juand.ramirez@urosario.edu.co.

Funding

Wellcome TrustWellcome Trust 098051
6 · The paper itself

Abstract

Clostridium difficile, the causal agent of antibiotic-associated diarrhea, has a complex epidemiology poorly studied in Latin America. We performed a robust genomic and phenotypic profiling of 53 C. difficile clinical isolates established from diarrheal samples from either intrahospital (IH) or community (CO) populations in central Colombia. In vitro tests were conducted to evaluate the cytopathic effect, the minimum inhibitory concentration of ten antimicrobial agents, the sporulation efficiency and the colony forming ability. Eleven different sequence types (STs) were found, the majority present individually in each sample, however in three samples two different STs were isolated. Interestingly, CO patients were infected with STs associated with hypervirulent strains (ST-1 in Clade-2). Three coexistence events (two STs simultaneously detected in the same sample) were observed always involving ST-8 from Clade-1. A total of 2,502 genes were present in 99% of the isolates with 95% of identity or more, it represents a core genome of 28.6% of the 8,735 total genes identified in the set of genomes. A high cytopathic effect was observed for the isolates positive for the two main toxins but negative for binary toxin (TcdA+/TcdB+/CDT- toxin production type), found only in Clade-1. Molecular markers conferring resistance to fluoroquinolones (cdeA and gyrA) and to sulfonamides (folP) were the most frequent in the analyzed genomes. In addition, 15 other markers were found mostly in Clade-2 isolates. These results highlight the regional differences that C. difficile isolates display, being in this case the CO isolates the ones having a greater number of accessory genes and virulence-associated factors.

Indexed as

Molecular EpidemiologyAnti-Infective AgentsClostridioides difficileClostridium InfectionsColombiaDiarrheaDrug Resistance, BacterialEnterotoxinsFluoroquinolonesGenome, BacterialGenomicsHospitalsHumansMicrobial Sensitivity TestsPhenotypeAnti-Infective AgentsEnterotoxinsFluoroquinolones

Identifiers

PMID31383872
PMCPMC6683185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.